These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9678918)

  • 21. Evolved streptavidin mutants reveal key role of loop residue in high-affinity binding.
    Magalhães ML; Czekster CM; Guan R; Malashkevich VN; Almo SC; Levy M
    Protein Sci; 2011 Jul; 20(7):1145-54. PubMed ID: 21520321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A streptavidin variant with slower biotin dissociation and increased mechanostability.
    Chivers CE; Crozat E; Chu C; Moy VT; Sherratt DJ; Howarth M
    Nat Methods; 2010 May; 7(5):391-3. PubMed ID: 20383133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A favorable solubility partner for the recombinant expression of streptavidin.
    Sørensen HP; Sperling-Petersen HU; Mortensen KK
    Protein Expr Purif; 2003 Dec; 32(2):252-9. PubMed ID: 14965771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A distal point mutation in the streptavidin-biotin complex preserves structure but diminishes binding affinity: experimental evidence of electronic polarization effects?
    Baugh L; Le Trong I; Cerutti DS; Gülich S; Stayton PS; Stenkamp RE; Lybrand TP
    Biochemistry; 2010 Jun; 49(22):4568-70. PubMed ID: 20462252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered chimeric streptavidin tetramers as novel tools for bioseparations and drug delivery.
    Chilkoti A; Schwartz BL; Smith RD; Long CJ; Stayton PS
    Biotechnology (N Y); 1995 Nov; 13(11):1198-1204. PubMed ID: 9636292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The origin of the cooperativity in the streptavidin-biotin system: A computational investigation through molecular dynamics simulations.
    Liu F; Zhang JZ; Mei Y
    Sci Rep; 2016 Jun; 6():27190. PubMed ID: 27249234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically engineered clostridial C2 toxin as a novel delivery system for living mammalian cells.
    Fahrer J; Plunien R; Binder U; Langer T; Seliger H; Barth H
    Bioconjug Chem; 2010 Jan; 21(1):130-9. PubMed ID: 20030334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High resolution structure of streptavidin in complex with a novel high affinity peptide tag mimicking the biotin binding motif.
    Perbandt M; Bruns O; Vallazza M; Lamla T; Betzel Ch; Erdmann VA
    Proteins; 2007 Jun; 67(4):1147-53. PubMed ID: 17377987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering Streptavidin and a Streptavidin-Binding Peptide with Infinite Binding Affinity and Reversible Binding Capability: Purification of a Tagged Recombinant Protein to High Purity via Affinity-Driven Thiol Coupling.
    Fogen D; Wu SC; Ng KK; Wong SL
    PLoS One; 2015; 10(9):e0139137. PubMed ID: 26406477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of a bifunctional fusion protein for ovarian cancer drug delivery: single-chain anti-CA125 core-streptavidin fusion protein.
    Wang WW; Das D; McQuarrie SA; Suresh MR
    Eur J Pharm Biopharm; 2007 Mar; 65(3):398-405. PubMed ID: 17257818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering soluble monomeric streptavidin with reversible biotin binding capability.
    Wu SC; Wong SL
    J Biol Chem; 2005 Jun; 280(24):23225-31. PubMed ID: 15840576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amine Landscaping to Maximize Protein-Dye Fluorescence and Ultrastable Protein-Ligand Interaction.
    Jacobsen MT; Fairhead M; Fogelstrand P; Howarth M
    Cell Chem Biol; 2017 Aug; 24(8):1040-1047.e4. PubMed ID: 28757182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of streptavidins with varying biotin binding affinities on the properties of biotinylated gramicidin channels.
    Antonenko YN; Rokitskaya TI; Kotova EA; Reznik GO; Sano T; Cantor CR
    Biochemistry; 2004 Apr; 43(15):4575-82. PubMed ID: 15078104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant streptavidin fusion proteins as signal reporters in rapid test of human hepatitis C virus infection.
    Zhou S; Cao S; Ma G; Ding T; Mu J; Han W; Sun D; Chen C
    J Clin Lab Anal; 2019 Mar; 33(3):e22701. PubMed ID: 30350885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of streptavidin mutant with low immunogenicity.
    Kawato T; Mizohata E; Meshizuka T; Doi H; Kawamura T; Matsumura H; Yumura K; Tsumoto K; Kodama T; Inoue T; Sugiyama A
    J Biosci Bioeng; 2015 Jun; 119(6):642-7. PubMed ID: 25434833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The free energies for mutating S27 and W79 to alanine in streptavidin and its biotin complex: the relative size of polar and nonpolar free energies on biotin binding.
    Dixon RW; Kollman P
    Proteins; 1999 Sep; 36(4):471-3. PubMed ID: 10450089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered streptavidin monomer and dimer with improved stability and function.
    Lim KH; Huang H; Pralle A; Park S
    Biochemistry; 2011 Oct; 50(40):8682-91. PubMed ID: 21892837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification of CD47-streptavidin fusion protein from bacterial lysate using biotin-agarose affinity chromatography.
    Salehi N; Peng CA
    Biotechnol Prog; 2016 Jul; 32(4):949-58. PubMed ID: 27110670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of streptavidin-luciferase fusion protein for ATP sensing with fixed form.
    Nakamura M; Mie M; Funabashi H; Kobatake E
    Biotechnol Lett; 2004 Jul; 26(13):1061-6. PubMed ID: 15218380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of new biotin/streptavidin reagents for pretargeting.
    Wilbur DS; Pathare PM; Hamlin DK; Stayton PS; To R; Klumb LA; Buhler KR; Vessella RL
    Biomol Eng; 1999 Dec; 16(1-4):113-8. PubMed ID: 10796993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.